Microkeratomes go head-to-head with the femtosecond

Article

The M2 microkeratome (Moria), the Carriazo-Pendular microkeratome (Schwind) and the IntraLase femtosecond laser all create flaps of predictable thickness.

The M2 microkeratome (Moria), the Carriazo-Pendular microkeratome (Schwind) and the IntraLase femtosecond laser all create flaps of predictable thickness, according to a report published in the January issue of the Journal of Refractive Surgery.

Jorge Alió from Vissum/Instituto Oftalmológico de Alicante and David Piñero from Universidad Miguel Hernández, Alicante, Spain evaluated the corneal aberrometric outcomes and corneal flap thickness profiles following LASIK using three different devices for lamellar keratotomy. A total of 66 myopic eyes (33 patients) were enrolled and were randomly assigned to either of the two microkeratomes or the femtosecond laser. Intended flap thickness was 110 µm in all cases.

Mean central flap thickness was 117.50±7.80, 118.08±8.4 and 115.95±6.22 µm for the M2, Carriazo-Pendular and IntraLase systems, respectively. No significant differences were found among the groups. Nasal thickness was significantly larger for the M2 flaps compared with IntraLase (p<0.05) and Carriazo-Pendular flaps (p=0.046, only at 3 mm position). Temporal thicknesses were larger for the M2 flaps, although only differences between M2 and Carriazo-Pendular flaps reached statistical significance. Larger superior and inferior thicknesses were also observed for the M2 flaps, although no statistically significant differences were found. With regards to corneal aberrometry, no statistically significant differences were observed in coma-like (p=0.138) and spherical-like RMS (p=0.300).

Each of the three systems created predictable flap thicknesses and, furthermore, the Carriazo-Pendular and IntraLase devices created flaps with a planar profile.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.